Marc R LaRochelle, MD, MPH
Fax referral information to 617.414.9251
Call for assistance with the referral process
Featured on HealthCity
HEALing Communities Study data underscores the need for racially inclusive approaches to address the opioid epidemic in vulnerable neighborhoods.
Treatment and harm reduction approaches for opioid use disorder have failed to effectively meet the needs of people of color, experts say.
It is expected that by 2030, more than 257,000 people with opioid use disorder will have died from endocarditis associated with injection drug use.
A new report collects evidence-based strategies to help hospitals stem the tide of opioid use and overdose deaths.
Efforts to restrict the prescription opioid supply haven't matched reductions in opioid-related harms. New research highlights areas of opportunity.
More About Me
Dr Marc Larochelle is a general internist and clinical investigator specializing in addiction medicine at BMC and an assistant professor of medicine at Boston University School of Medicine. Dr Larochelle’s clinical and research interests focus on the safety of opioid prescribing and the recognition and treatment of opioid use disorders.
University of Pittsburgh School of Medicine, Pittsburg PA (2009)
801 Massachusetts Ave
Boston, MA 02119
Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.
As the principal teaching affiliate of Boston University School of Medicine (BUSM), Boston Medical Center is devoted to training future generations of healthcare professionals.